Wells Fargo & Company Forecasts Strong Price Appreciation for GE HealthCare Technologies (NASDAQ:GEHC) Stock

GE HealthCare Technologies (NASDAQ:GEHC) had its price target hoisted by equities research analysts at Wells Fargo & Company from $95.00 to $97.00 in a research report issued on Thursday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. Wells Fargo & Company‘s target price suggests a potential upside of 16.62% from the stock’s current price.

Several other equities research analysts have also recently weighed in on the company. Jefferies Financial Group increased their price target on GE HealthCare Technologies from $95.00 to $105.00 and gave the company a “buy” rating in a research note on Thursday, December 11th. UBS Group cut shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and upped their price target for the stock from $73.00 to $77.00 in a research note on Thursday, January 15th. BTIG Research raised their price objective on shares of GE HealthCare Technologies from $87.00 to $91.00 and gave the company a “buy” rating in a research note on Wednesday. Morgan Stanley upped their target price on shares of GE HealthCare Technologies from $80.00 to $85.00 and gave the stock an “equal weight” rating in a research note on Wednesday. Finally, Bank of America raised their price target on shares of GE HealthCare Technologies from $82.00 to $92.00 and gave the company a “neutral” rating in a research report on Monday, January 5th. Seven investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, GE HealthCare Technologies presently has a consensus rating of “Hold” and an average target price of $92.42.

GE HealthCare Technologies Stock Performance

Shares of GEHC stock traded up $0.55 during trading on Thursday, reaching $83.18. 965,178 shares of the company’s stock were exchanged, compared to its average volume of 3,547,594. The firm’s fifty day moving average price is $82.68 and its 200-day moving average price is $77.47. GE HealthCare Technologies has a twelve month low of $57.65 and a twelve month high of $94.80. The stock has a market capitalization of $37.89 billion, a PE ratio of 17.18, a PEG ratio of 2.38 and a beta of 1.08. The company has a quick ratio of 0.95, a current ratio of 1.18 and a debt-to-equity ratio of 0.83.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share for the quarter, topping analysts’ consensus estimates of $1.40 by $0.04. The company had revenue of $5.70 billion for the quarter, compared to analyst estimates of $5.60 billion. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.The firm’s quarterly revenue was up 7.1% compared to the same quarter last year. During the same quarter last year, the company earned $1.45 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. As a group, sell-side analysts anticipate that GE HealthCare Technologies will post 4.68 EPS for the current year.

Institutional Trading of GE HealthCare Technologies

Institutional investors and hedge funds have recently modified their holdings of the company. Laurel Wealth Advisors LLC bought a new position in shares of GE HealthCare Technologies during the fourth quarter worth approximately $26,000. Optima Capital LLC acquired a new position in shares of GE HealthCare Technologies during the fourth quarter worth $27,000. Montag A & Associates Inc. grew its stake in shares of GE HealthCare Technologies by 105.4% in the fourth quarter. Montag A & Associates Inc. now owns 341 shares of the company’s stock worth $28,000 after purchasing an additional 175 shares during the last quarter. Godsey & Gibb Inc. bought a new position in GE HealthCare Technologies during the 3rd quarter worth $26,000. Finally, E Fund Management Hong Kong Co. Ltd. grew its position in shares of GE HealthCare Technologies by 130.7% in the 3rd quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company’s stock valued at $26,000 after buying an additional 196 shares during the last quarter. 82.06% of the stock is currently owned by institutional investors and hedge funds.

Key Headlines Impacting GE HealthCare Technologies

Here are the key news stories impacting GE HealthCare Technologies this week:

• Positive Sentiment: Q4 results beat consensus — EPS $1.44 vs. ~$1.40 and revenue $5.70B (up ~7% y/y), reflecting strength in Imaging and Pharmaceutical Diagnostics; management provided slides and commentary underscoring growth drivers. GE HealthCare reports fourth quarter and full year 2025 financial results
• Positive Sentiment: FY‑2026 guidance raised and above consensus — company set EPS guidance of $4.95–$5.15 (slightly above Street), which supports upside to estimates and the stock’s re-rating into the mid‑teens P/E range. Reuters: GE HealthCare forecasts 2026 profit above estimates
• Positive Sentiment: Analyst bullishness — BTIG raised its price target to $91 and kept a Buy, signaling analyst confidence in upside from current levels and validating the beat/guidance reaction. StreetInsider: PT Raised to $91 at BTIG
• Positive Sentiment: Regulatory win expands product lineup — FDA clearance and CE mark for the Allia Moveo mobile C‑arm (AI guidance, compact design) supports commercialization and incremental imaging revenue. Zacks: GEHC wins FDA clearance & CE mark for Allia Moveo
• Neutral Sentiment: Earnings call transcript and details available — full management commentary and Q&A (useful for modeling guidance drivers and margin outlook). Seeking Alpha: Q4 2025 Earnings Call Transcript
• Neutral Sentiment: Company materials posted — press release, slide deck and conference call recording are available for deeper review of segment trends and FY guidance assumptions. MarketBeat: Earnings report and materials
• Negative Sentiment: Margin pressure and lower profit — net margin declined (tariffs, product mix and investments were cited) and headline profit fell versus prior year despite higher revenue, which could cap near‑term margin expansion. Zacks: Net margin falls WSJ: Posts lower profit despite higher revenue

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.